Cargando…
NPC1L1 knockout protects against colitis-associated tumorigenesis in mice
BACKGROUND: Colorectal cancer is strongly associated with lipid metabolism. NPC1L1, a sterol transporter, plays a key role in modulating lipid homeostasis in vivo. Its inhibitor, ezetimibe, began to be used clinically to lower cholesterol and this caused the great debate on its role in causing carci...
Autores principales: | He, Jianming, Shin, Hyunsu, Wei, Xing, Kadegowda, Anil Kumar G, Chen, Rui, Xie, Sandy Krystal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378275/ https://www.ncbi.nlm.nih.gov/pubmed/25881076 http://dx.doi.org/10.1186/s12885-015-1230-0 |
Ejemplares similares
-
The role of NPC1L1 in cancer
por: Zhang, Renshuai, et al.
Publicado: (2022) -
Inter-domain dynamics drive cholesterol transport by NPC1 and NPC1L1 proteins
por: Saha, Piyali, et al.
Publicado: (2020) -
Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis
por: Wu, Chung-Chun, et al.
Publicado: (2019) -
EBV reactivation as a target of luteolin to repress NPC tumorigenesis
por: Wu, Chung-Chun, et al.
Publicado: (2016) -
Recruitment of M1 Macrophages May Not Be Critical for Protection against Colitis-Associated Tumorigenesis
por: Medina-Andrade, Itzel, et al.
Publicado: (2021)